← 產業報告目錄
Neurofilament Protein Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 112報告編號 APO-ffc136a2e3
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Neurofilament Protein market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Neurofilament Protein market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Neurofilament Protein market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Neurofilament Protein market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Neurofilament Protein include Merck, Sigma Aldrich Biotechnology, Rockland Immunochemicals, OriGene Technologies, EnCor Biotechnology, Cell Signaling Technology, Bio-Rad Laboratories and BioLegend, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Neurofilament Protein market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Neurofilament Protein.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neurofilament Protein Market by Company
Merck
Sigma Aldrich Biotechnology
Rockland Immunochemicals
OriGene Technologies
EnCor Biotechnology
Cell Signaling Technology
Bio-Rad Laboratories
BioLegend
Neurofilament Protein Segment by Type
Neurofilament Protein H
Neurofilament Protein L
Neurofilament Protein M
Neurofilament Protein Segment by Application
Medical Care
Research
Other
Neurofilament Protein Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurofilament Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurofilament Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurofilament Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Neurofilament Protein companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Neurofilament Protein by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Neurofilament Protein H
2.2.3 Neurofilament Protein L
2.2.4 Neurofilament Protein M
2.3 Neurofilament Protein by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Medical Care
2.3.3 Research
2.3.4 Other
2.4 Assumptions and Limitations
3 Neurofilament Protein Breakdown Data by Type
3.1 Global Neurofilament Protein Historic Market Size by Type (2021-2026)
3.2 Global Neurofilament Protein Forecasted Market Size by Type (2027-2032)
4 Neurofilament Protein Breakdown Data by Application
4.1 Global Neurofilament Protein Historic Market Size by Application (2021-2026)
4.2 Global Neurofilament Protein Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global Neurofilament Protein Market Perspective (2021-2032)
5.2 Global Neurofilament Protein Growth Trends by Region
5.2.1 Global Neurofilament Protein Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 Neurofilament Protein Historic Market Size by Region (2021-2026)
5.2.3 Neurofilament Protein Forecasted Market Size by Region (2027-2032)
5.3 Neurofilament Protein Market Dynamics
5.3.1 Neurofilament Protein Industry Trends
5.3.2 Neurofilament Protein Market Drivers
5.3.3 Neurofilament Protein Market Challenges
5.3.4 Neurofilament Protein Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Neurofilament Protein Players by Revenue
6.1.1 Global Top Neurofilament Protein Players by Revenue (2021-2026)
6.1.2 Global Neurofilament Protein Revenue Market Share by Players (2021-2026)
6.2 Global Neurofilament Protein Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Neurofilament Protein Head Office and Area Served
6.4 Global Neurofilament Protein Players, Product Type & Application
6.5 Global Neurofilament Protein Manufacturers Established Date
6.6 Global Neurofilament Protein Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Neurofilament Protein Market Size (2021-2032)
7.2 North America Neurofilament Protein Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America Neurofilament Protein Market Size by Country (2021-2026)
7.4 North America Neurofilament Protein Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Neurofilament Protein Market Size (2021-2032)
8.2 Europe Neurofilament Protein Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe Neurofilament Protein Market Size by Country (2021-2026)
8.4 Europe Neurofilament Protein Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Neurofilament Protein Market Size (2021-2032)
9.2 Asia-Pacific Neurofilament Protein Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific Neurofilament Protein Market Size by Country (2021-2026)
9.4 Asia-Pacific Neurofilament Protein Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Neurofilament Protein Market Size (2021-2032)
10.2 South America Neurofilament Protein Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America Neurofilament Protein Market Size by Country (2021-2026)
10.4 South America Neurofilament Protein Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Neurofilament Protein Market Size (2021-2032)
11.2 Middle East & Africa Neurofilament Protein Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa Neurofilament Protein Market Size by Country (2021-2026)
11.4 Middle East & Africa Neurofilament Protein Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Merck
12.1.1 Merck Company Information
12.1.2 Merck Business Overview
12.1.3 Merck Revenue in Neurofilament Protein Business (2021-2026)
12.1.4 Merck Neurofilament Protein Product Portfolio
12.1.5 Merck Recent Developments
12.2 Sigma Aldrich Biotechnology
12.2.1 Sigma Aldrich Biotechnology Company Information
12.2.2 Sigma Aldrich Biotechnology Business Overview
12.2.3 Sigma Aldrich Biotechnology Revenue in Neurofilament Protein Business (2021-2026)
12.2.4 Sigma Aldrich Biotechnology Neurofilament Protein Product Portfolio
12.2.5 Sigma Aldrich Biotechnology Recent Developments
12.3 Rockland Immunochemicals
12.3.1 Rockland Immunochemicals Company Information
12.3.2 Rockland Immunochemicals Business Overview
12.3.3 Rockland Immunochemicals Revenue in Neurofilament Protein Business (2021-2026)
12.3.4 Rockland Immunochemicals Neurofilament Protein Product Portfolio
12.3.5 Rockland Immunochemicals Recent Developments
12.4 OriGene Technologies
12.4.1 OriGene Technologies Company Information
12.4.2 OriGene Technologies Business Overview
12.4.3 OriGene Technologies Revenue in Neurofilament Protein Business (2021-2026)
12.4.4 OriGene Technologies Neurofilament Protein Product Portfolio
12.4.5 OriGene Technologies Recent Developments
12.5 EnCor Biotechnology
12.5.1 EnCor Biotechnology Company Information
12.5.2 EnCor Biotechnology Business Overview
12.5.3 EnCor Biotechnology Revenue in Neurofilament Protein Business (2021-2026)
12.5.4 EnCor Biotechnology Neurofilament Protein Product Portfolio
12.5.5 EnCor Biotechnology Recent Developments
12.6 Cell Signaling Technology
12.6.1 Cell Signaling Technology Company Information
12.6.2 Cell Signaling Technology Business Overview
12.6.3 Cell Signaling Technology Revenue in Neurofilament Protein Business (2021-2026)
12.6.4 Cell Signaling Technology Neurofilament Protein Product Portfolio
12.6.5 Cell Signaling Technology Recent Developments
12.7 Bio-Rad Laboratories
12.7.1 Bio-Rad Laboratories Company Information
12.7.2 Bio-Rad Laboratories Business Overview
12.7.3 Bio-Rad Laboratories Revenue in Neurofilament Protein Business (2021-2026)
12.7.4 Bio-Rad Laboratories Neurofilament Protein Product Portfolio
12.7.5 Bio-Rad Laboratories Recent Developments
12.8 BioLegend
12.8.1 BioLegend Company Information
12.8.2 BioLegend Business Overview
12.8.3 BioLegend Revenue in Neurofilament Protein Business (2021-2026)
12.8.4 BioLegend Neurofilament Protein Product Portfolio
12.8.5 BioLegend Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Neurofilament Protein Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Neurofilament Protein Revenue Market Share by Type (2021-2026)
Table 7. Global Neurofilament Protein Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Neurofilament Protein Revenue Market Share by Type (2027-2032)
Table 9. Global Neurofilament Protein Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Neurofilament Protein Revenue Market Share by Application (2021-2026)
Table 11. Global Neurofilament Protein Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Neurofilament Protein Revenue Market Share by Application (2027-2032)
Table 13. Global Neurofilament Protein Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Neurofilament Protein Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Neurofilament Protein Market Share by Region (2021-2026)
Table 16. Global Neurofilament Protein Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Neurofilament Protein Market Share by Region (2027-2032)
Table 18. Neurofilament Protein Industry Trends
Table 19. Neurofilament Protein Industry Drivers
Table 20. Neurofilament Protein Industry Opportunities and Challenges
Table 21. Neurofilament Protein Market Restraints
Table 22. Global Top Neurofilament Protein Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Neurofilament Protein Revenue Market Share by Players (2021-2026)
Table 24. Global Neurofilament Protein Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Neurofilament Protein, Headquarters and Area Served
Table 26. Global Neurofilament Protein Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Neurofilament Protein by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Neurofilament Protein Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Neurofilament Protein Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Neurofilament Protein Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Neurofilament Protein Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Neurofilament Protein Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Neurofilament Protein Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Neurofilament Protein Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Neurofilament Protein Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Neurofilament Protein Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Neurofilament Protein Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Neurofilament Protein Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Neurofilament Protein Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Neurofilament Protein Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Neurofilament Protein Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Neurofilament Protein Market Size by Country (2027-2032) & (US$ Million)
Table 45. Merck Company Information
Table 46. Merck Business Overview
Table 47. Merck Revenue in Neurofilament Protein Business (2021-2026) & (US$ Million)
Table 48. Merck Neurofilament Protein Product Portfolio
Table 49. Merck Recent Developments
Table 50. Sigma Aldrich Biotechnology Company Information
Table 51. Sigma Aldrich Biotechnology Business Overview
Table 52. Sigma Aldrich Biotechnology Revenue in Neurofilament Protein Business (2021-2026) & (US$ Million)
Table 53. Sigma Aldrich Biotechnology Neurofilament Protein Product Portfolio
Table 54. Sigma Aldrich Biotechnology Recent Developments
Table 55. Rockland Immunochemicals Company Information
Table 56. Rockland Immunochemicals Business Overview
Table 57. Rockland Immunochemicals Revenue in Neurofilament Protein Business (2021-2026) & (US$ Million)
Table 58. Rockland Immunochemicals Neurofilament Protein Product Portfolio
Table 59. Rockland Immunochemicals Recent Developments
Table 60. OriGene Technologies Company Information
Table 61. OriGene Technologies Business Overview
Table 62. OriGene Technologies Revenue in Neurofilament Protein Business (2021-2026) & (US$ Million)
Table 63. OriGene Technologies Neurofilament Protein Product Portfolio
Table 64. OriGene Technologies Recent Developments
Table 65. EnCor Biotechnology Company Information
Table 66. EnCor Biotechnology Business Overview
Table 67. EnCor Biotechnology Revenue in Neurofilament Protein Business (2021-2026) & (US$ Million)
Table 68. EnCor Biotechnology Neurofilament Protein Product Portfolio
Table 69. EnCor Biotechnology Recent Developments
Table 70. Cell Signaling Technology Company Information
Table 71. Cell Signaling Technology Business Overview
Table 72. Cell Signaling Technology Revenue in Neurofilament Protein Business (2021-2026) & (US$ Million)
Table 73. Cell Signaling Technology Neurofilament Protein Product Portfolio
Table 74. Cell Signaling Technology Recent Developments
Table 75. Bio-Rad Laboratories Company Information
Table 76. Bio-Rad Laboratories Business Overview
Table 77. Bio-Rad Laboratories Revenue in Neurofilament Protein Business (2021-2026) & (US$ Million)
Table 78. Bio-Rad Laboratories Neurofilament Protein Product Portfolio
Table 79. Bio-Rad Laboratories Recent Developments
Table 80. BioLegend Company Information
Table 81. BioLegend Business Overview
Table 82. BioLegend Revenue in Neurofilament Protein Business (2021-2026) & (US$ Million)
Table 83. BioLegend Neurofilament Protein Product Portfolio
Table 84. BioLegend Recent Developments
Table 85. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Neurofilament Protein Product Image
Figure 5. Global Neurofilament Protein Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Neurofilament Protein Market Share by Type: 2025 VS 2032
Figure 7. Neurofilament Protein H Product
Figure 8. Neurofilament Protein L Product
Figure 9. Neurofilament Protein M Product
Figure 10. Global Neurofilament Protein Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Neurofilament Protein Market Share by Application: 2025 VS 2032
Figure 12. Medical Care Product
Figure 13. Research Product
Figure 14. Other Product
Figure 15. Global Neurofilament Protein Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 16. Global Neurofilament Protein Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 17. Global Neurofilament Protein Market Share by Region: 2025 VS 2032
Figure 18. Global Neurofilament Protein Market Share by Players in 2025
Figure 19. Global Neurofilament Protein Manufacturers Established Date
Figure 20. Global Top 5 and 10 Neurofilament Protein Players Market Share by Revenue in 2025
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 22. North America Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 23. North America Neurofilament Protein Market Share by Country (2021-2032)
Figure 24. United States Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Canada Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Mexico Neurofilament Protein Market Share by Country (2021-2032)
Figure 27. Europe Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Europe Neurofilament Protein Market Share by Country (2021-2032)
Figure 29. Germany Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. France Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. U.K. Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Italy Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Spain Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Russia Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Netherlands Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Nordic Countries Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Asia-Pacific Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific Neurofilament Protein Market Share by Country (2021-2032)
Figure 39. China Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Japan Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. South Korea Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. India Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India Neurofilament Protein Market Share by Country (2021-2032)
Figure 44. Australia Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. China Taiwan Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. Southeast Asia Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. South America Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America Neurofilament Protein Market Share by Country (2021-2032)
Figure 49. Brazil Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Argentina Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Chile Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Colombia Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Peru Neurofilament Protein Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Merck Revenue Growth Rate in Neurofilament Protein Business (2021-2026)
Figure 55. Sigma Aldrich Biotechnology Revenue Growth Rate in Neurofilament Protein Business (2021-2026)
Figure 56. Rockland Immunochemicals Revenue Growth Rate in Neurofilament Protein Business (2021-2026)
Figure 57. OriGene Technologies Revenue Growth Rate in Neurofilament Protein Business (2021-2026)
Figure 58. EnCor Biotechnology Revenue Growth Rate in Neurofilament Protein Business (2021-2026)
Figure 59. Cell Signaling Technology Revenue Growth Rate in Neurofilament Protein Business (2021-2026)
Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Neurofilament Protein Business (2021-2026)
Figure 61. BioLegend Revenue Growth Rate in Neurofilament Protein Business (2021-2026)
提及公司
MerckSigma Aldrich BiotechnologyRockland ImmunochemicalsOriGene TechnologiesEnCor BiotechnologyCell Signaling TechnologyBio-Rad LaboratoriesBioLegend
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們